Guide to Receptors and Channels, 2nd edition (2007 Revision).

Guide to Receptors and Channels, 2nd edition (2007 Revision). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Guide to Receptors and Channels, 2nd edition (2007 Revision). Abstract Text:

S P H Alexander,A Mathie,J A Peters,

Guide to Receptors and Channels, 2nd edition (2007 Revision). Publishing Authors By Initials

SP Alexander,A Mathie,JA Peters,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Guide to Receptors and Channels, 2nd edition (2007 Revision). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: British journal of pharmacology

VOLUME: 150 Suppl 1

Page Numbers: S1

Journal Abbreviation: Br. J. Pharmacol.

ISSN: 0007-1188

DAY: 6

MONTH: Feb

YEAR: 2007

Guide to Receptors and Channels, 2nd edition (2007 Revision). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7502536

Guide to Receptors and Channels, 2nd edition (2007 Revision). Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Guide to Receptors and Channels, 2nd edition (2007 Revision). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Guide to Receptors and Channels, 2nd edition (2007 Revision).

AFFILIATION:

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Pharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Guide to Receptors and Channels, 2nd edition 2007 Revision Related Publications

• A mouse TRAPP-related protein is involved in pigmentation.
• Assessment of the factors affecting the volume of fetally derived tissue in the bovine placentome.
• Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
• Catalytic receptors.
• Cell-surface transmitter transporters.
• Commentary left and right in classical Greece and Italy.
• Cooperative learning: a new application of problem-based learning in mental health training.
• De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
• Determination of etoposide (VP16-213) and teniposide (VM-26) in serum by high-performance liquid chromatography with electrochemical detection.
• Dog ownership enhances symptomatic responses to air pollution in children with asthma.
• Fe(I)-mediated reductive cleavage and coupling of CO(2): an Fe(II)(mu-O, mu-CO)Fe(II) core.
• Functional characterization of the rice kaurene synthase-like gene family.
• Guide to Receptors and Channels, 2nd edition (2007 Revision).
• Immune epitope mapping in the post-genomic era: lessons for vaccine development.
• Long-term consequences of pain in human neonates.
• Nanoscopic medicine: the next frontier.
• Neuromodulation for the treatment of refractory interstitial cystitis.
• Novel model of antigen-specific induction of bile duct injury.
• Nuclear receptors.
• On the feasibility of N2 fixation via a single-site FeI/FeIV cycle: Spectroscopic studies of FeI(N2)FeI, FeIV[triple bond]N, and related species.
• Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations.
• Prospective study of air pollution and bronchitic symptoms in children with asthma.
• Pseudotetrahedral manganese complexes supported by the anionic tris(phosphino)borate ligand [PhBP(iPr)3].
• Regular smoking and asthma incidence in adolescents.
• Separation of ribonucleotides, deoxynucleotides, cyclic nucleotides and deoxycyclic nucleotides by reversed-phase high-performance liquid chromatography.
• Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor.
• Skeletal muscle fiber type comparison of pyruvate dehydrogenase phosphatase activity and isoform expression in fed and food-deprived rats.
• Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN.
• The challenge of managing body weight in the modern world.
• Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck.